In-House Radio-Labelling Of 131i-Rituximab In Threatment Of Cd20+ B-Cell Non-Hodgkin’s Lymphoma: A Pioneer Experience In Malaysia

QR Code

In-House Radio-Labelling Of 131i-Rituximab In Threatment Of Cd20+ B-Cell Non-Hodgkin’s Lymphoma: A Pioneer Experience In Malaysia

Background Radioimmunotherapy (RIT) is an established treatment modality in Non-Hodgkin’s lymphoma (NHL). The only two commercially available RITs - 90Y-ibritumomab tiuxetan (Zevalin®) is expensive and 131I-tositumomab has been discontinued from commercial production. In resource limited environm...

Full description

Bibliographic Details
Main Authors:	Kuan, Jew Win, Law, Chiong Soon, Wong, Xiang Qi, Ko, Ching Tiong, Awang, Zool Hilmi, Chew, Lee Ping, Chang, Kian Meng
Format:	Proceeding
Language:	English
Published:	2016
Subjects:	RZ Other systems of medicine
Online Access:	http://ir.unimas.my/id/eprint/12287/ http://ir.unimas.my/id/eprint/12287/3/IN-HOUSE%20RADIO-LABELLING%20OF%20131I-RITUXIMAB%20IN%20THREATMENT%20OF%20CD20%2B%20B-CELL%20NON-HODGKIN%E2%80%99S%20LYMPHOMA.pdf

Similar Items

A pioneer experience in Malaysia on In-house Radio-labelling of 131I-rituximab in the treatment of Non-Hodgkin's Lymphoma and a case report of high dose 131I-rituximab-BEAM conditioning autologous transplant
by: Jew, Win Kuan, et al.
Published: (2016)

Socioeconomic Inequality in the Use of Rituximab Therapy Among Non-Hodgkin Lymphoma Patients in Chinese Public Hospitals
by: Huang, Y., et al.
Published: (2012)

Does Chinese Medical Insurance System Affect Selection of Rituximab Therapy Among Patients with Non-Hodgkin Lymphoma?
by: Jian, Le, et al.
Published: (2012)

Clinical association with non-hodgkin lymphoma
by: Abdullah, Wan Zaidah
Published: (2004)

Multiple cavitating pulmonary nodules secondary to Hodgkin's lymphoma
by: Abdul Azih, Muhammad Naimmuddin, et al.
Published: (2017)

Non-neoformans cryptococcemia in a patient with hodgkin’s lymphoma
by: Ding, Chuanhun, et al.
Published: (2018)

Lifetime physical activity and the risk of non-Hodgkin lymphoma
by: Boyle, Terry, et al.
Published: (2015)

Oral cavity non-Hodgkin’s lymphoma: Clinicopathological aspects
by: Shweta N Kalyankar,
Published: (2015)

Aleukemic bcr-abl positive granulocytic sarcoma
by: Kuan, Jew-Win, et al.
Published: (2009)

Biochemical analysis of the BTG1 variants associated with Non-Hodgkin’s lymphoma
by: Almasmoum, Hibah
Published: (2017)

Reactive oxygen species and aldehyde dehydrogenase activity in Hodgkin lymphoma cells
by: Ikeda, Jun-ichiro, et al.
Published: (2012)

Tumorigenic potential of mononucleated small cells of Hodgkin lymphoma cell lines
by: Ikeda, Jun-ichiro, et al.
Published: (2010)

Kimura’s disease Mimicking Hodgkin’s Lymphoma: An unusual cause of parotid swelling
by: S-A-W Fadilah,, et al.
Published: (2007)

Primary non-Hodgkin's lymphoma presenting as a uterine cervical mass.
by: Ab. Hamid, Suzana, et al.
Published: (2008)

Pegylated granulocyte colony stimulating factor versus nonpegylated granulocyte colony stimulating factor for patients after hematopoietic stem cell transplantation (Protocol)
by: Kuan, Jew-Win, et al.
Published: (2012)

Non Hodgkin lymphoma presenting with adrenal insufficiency and bilateral huge adrenal masses
by: Huai, Heng Loh, et al.
Published: (2014)

Non-Hodgkin lymphoma and occupational radiation exposure assessed using local data
by: Karipidis, K., et al.
Published: (2009)

Microrna as a potential biomarker in the diagnosis and prognosis of Hodgkin’s lymphoma: a systematic review
by: Nik Izhar, Nik Nurdiyana, et al.
Published: (2019)

Analisis genetik molekul dan imunofenotip penyakit non-Hodgkin's lymphoma di Kelantan
by: Khairani Idah , Mokhtar
Published: (2001)

Primary Hodgkin’s lymphoma of the middle ear: A rare cause of facial nerve palsy
by: Maithrea, N., et al.
Published: (2017)

Analisis genetik molekul dan imunofenotip penyakit non-Hodgkin's lymphoma di Kelantan
by: Mokhtar, Khairani Idah
Published: (2001)

Validation of international prognostic index for non-hodgkin's lymphoma in northeast Peninsular Malaysian Malays
by: Abdullah, Abu Dzarr Ganesh
Published: (2002)

The Outcome of HyperCVAD Combined with Alemtuzumab for the Treatment of Aggressive T-Cell and NK-Cell Neoplasms.
by: Kuan, Jew-Win, et al.
Published: (2011)

Primary Hodgkin’s lymphoma with chest wall ulceration and hypereosinophilia: a rare presentation and diagnostic dilemma
by: Wan Ali, Wan Ahmad Syahril Rozli, et al.
Published: (2018)

Volume and correlates of objectively measured physical activity and sedentary time in non-Hodgkin lymphoma survivors
by: Boyle, Terry, et al.
Published: (2017)

Nodular lymphocyte-predominant hodgkin lymphoma: A rare indolent tumour with recurrence at extranodal sites
by: Rabab, NB, et al.
Published: (2011)

A randomized control trial comparing peginterferon-α-2a versus observation after stopping tyrosine kinase inhibitor in chronic myeloid leukemia with deep molecular response for at least two years
by: Kuan, Jew-Win, et al.
Published: (2016)

Occupation and risk of non-hodgkin lymphoma and its subtypes: A pooled analysis from the interlymph consortium
by: Mannetje, A., et al.
Published: (2016)

Survival analysis and prognostic factor of non-Hodgkin lymphoma treated in Hospital Universiti Sains Malaysia (HUSM)
by: Che Soh, Nur Sabrina, et al.
Published: (2011)

Factors associated with successful outcome of infertility threatment at Hospital Raja Perempuan Zainab II
by: Zakaria, Siti Aisyah
Published: (2015)

Reallocating time to sleep, sedentary, and active behaviours in non-Hodgkin lymphoma survivors: associations with patient-reported outcomes
by: Vallance, J., et al.
Published: (2017)

Colorectal cancer surveillance in Hodgkin lymphoma survivors at increased risk of therapy-related colorectal cancer: Study design
by: Rigter, L., et al.
Published: (2017)

Modelling cost-effectiveness of high-dose chemotherapy as treatment for relapsed aggressive non-Hodgkin lymphoma in an Australian setting
by: Prajogo, J., et al.
Published: (2009)

Survival rate and prognostic factors of death among patients with non-hodgkin lymphoma in Kelantan from 2008-2017
by: Nazmi, Omar
Published: (2024)

Association between interleukin-10 (IL-10) promoter polymorphisms and non hodgkin lymphoma in Malaysian population / Somayeh Fani
by: Fani, Somayeh
Published: (2011)

The evaluation of program death 1 and PD-1 ligand expressions in histological subtypes of primary extranodal non hodgkin lymphoma
by: Mohaidin, Farhana Mohammad
Published: (2021)

Effects of Morinda citrifolia on N-methyl N-nitrosourea-induced peripheral T cell non-Hodgkin's lymphoma in Sprague Dawley rats
by: Al-Salih, Hutheyfa A-H
Published: (2010)

S1PR1 drives a feedforward signaling loop to regulate BATF3 and the transcriptional programme of Hodgkin lymphoma cells
by: Vrzalikova, K., et al.
Published: (2017)

Rasgrp1 deficiency associated with diffuse mesangial sclerosis infantile nephrotic syndrome and Epstein-Barr virus-induced Hodgkin’s lymphoma
by: Mohamed Nashrudin, Khairoon Nisa, et al.
Published: (2025)

High-risk behaviours and concomitant medical illnesses among patients at Methadone Maintenance Therapy Clinic, Hospital Tengku Ampuan Afzan, Malaysia
by: Musa, Ramli, et al.
Published: (2009)